Cleo Diagnostics (ASX:COV) Current Deferred Taxes Liabilities: A$0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:COV Cleo Diagnostics Ltd ASX:COV
32 GF Score
Price A$0.33
! 1 Warning Sign
View Full Analysis

What is Cleo Diagnostics Current Deferred Taxes Liabilities?

Cleo Diagnostics ASX:COV +3.17% 32 Current Deferred Taxes Liabilities is A$0.00 Mil as of Jun. 2026. GuruFocus rates ASX:COV with a GF Score™ of 32/100. The stock has 1 warning sign investors should review.

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Cleo Diagnostics's current deferred tax liabilities for the quarter that ended in Jun. 2026 was A$0.00 Mil.

Cleo Diagnostics Current Deferred Taxes Liabilities Related Terms

Cleo Diagnostics Current Deferred Taxes Liabilities Historical Data

* Premium members only.

The historical data trend for Cleo Diagnostics's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cleo Diagnostics Current Deferred Taxes Liabilities Chart

Cleo Diagnostics Annual Data
Trend Jun23 Jun24 Jun25 Jun26
Current Deferred Taxes Liabilities
0.00 0.00 0.00 0.00

Cleo Diagnostics Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Current Deferred Taxes Liabilities Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
ASX:COV
32GF Score
Cleo Diagnostics Ltd ASX:COV
Current Deferred Taxes Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Taxes Liabilities of A$0.00 Mil mean?
Cleo Diagnostics (ASX:COV) has a Current Deferred Taxes Liabilities of A$0.00 Mil as of Jun. 2026. Current Deferred Tax Liabilities records the total amount of taxes due for the period but not yet paid. View historical data on Cleo Diagnostics and its competitors.
Is Cleo Diagnostics' Current Deferred Taxes Liabilities too high?
Cleo Diagnostics' current Current Deferred Taxes Liabilities is A$0.00 Mil. Overall, Cleo Diagnostics has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Cleo Diagnostics' Current Deferred Taxes Liabilities compare to ABT and SYK?
Cleo Diagnostics' Current Deferred Taxes Liabilities of A$0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Taxes Liabilities for a Medical Devices & Instruments company?
A good Current Deferred Taxes Liabilities depends on the Medical Devices & Instruments industry context. However, Current Deferred Taxes Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Taxes Liabilities mean?
A high Current Deferred Taxes Liabilities can signal that a stock is expensive relative to its fundamentals. Current Deferred Tax Liabilities records the total amount of taxes due for the period but not yet paid. View historical data on Cleo Diagnostics and its competitors. Cleo Diagnostics's current Current Deferred Taxes Liabilities is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cleo Diagnostics stock overvalued right now?
Cleo Diagnostics (ASX:COV) has a current Current Deferred Taxes Liabilities of A$0.00 Mil. The current Current Deferred Taxes Liabilities is A$0.00 Mil. Cleo Diagnostics' overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Taxes Liabilities calculated?
Current Deferred Taxes Liabilities is calculated from a company's financial statements. For Cleo Diagnostics (ASX:COV), the current Current Deferred Taxes Liabilities is A$0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cleo Diagnostics Business Description

Address 480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000
Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The company's first product to market is intended to be the Triage Test which results to accurately differentiate patients with malignant ovarian cancer from those with benign gynecological conditions. The company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.
32GF Score

Get the complete analysis for ASX:COV

Current Deferred Taxes Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.33
Price